What is it about?
The pharmacogenetics of ADME relating to anticancer strategies in Asians
Featured Image
Why is it important?
There must be recognition for pharmacoethnicity - that at a population-level, ethnic patient groups display differences in drug disposition
Perspectives
Will be helpful for translational scientists and physicians
Mr Nicholas Li-Xun Syn
National University Cancer Institute, Singapore
Read the Original
This page is a summary of: Genetic factors affecting drug disposition in Asian cancer patients, Expert Opinion on Drug Metabolism & Toxicology, November 2015, Informa Healthcare,
DOI: 10.1517/17425255.2015.1108964.
You can read the full text:
Contributors
The following have contributed to this page
